- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Kshirsagar, M.
- Articles by Parker, R.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Kshirsagar, M.
- Articles by Parker, R.
Identification of Edc3p as an Enhancer of mRNA Decapping in Saccharomyces cerevisiae
Meenakshi Kshirsagara and Roy Parkeraa Department of Molecular and Cellular Biology and Howard Hughes Medical Institute, University of Arizona, Tucson, Arizona 85721-0106
Corresponding author: Roy Parker, Life Sciences South Bldg., 1007 E. Lowell St., University of Arizona, Tucson, AZ 85721-0106., rrparker{at}u.arizona.edu (E-mail)
Communicating editor: P. ANDERSON
| ABSTRACT |
|---|
The major pathway of mRNA decay in yeast initiates with deadenylation, followed by mRNA decapping and 5'3' exonuclease digestion. An in silico approach was used to identify new proteins involved in the mRNA decay pathway. One such protein, Edc3p, was identified as a conserved protein of unknown function having extensive two-hybrid interactions with several proteins involved in mRNA decapping and 5'3' degradation including Dcp1p, Dcp2p, Dhh1p, Lsm1p, and the 5'3' exonuclease, Xrn1p. We show that Edc3p can stimulate mRNA decapping of both unstable and stable mRNAs in yeast when the decapping enzyme is compromised by temperature-sensitive alleles of either the DCP1 or the DCP2 genes. In these cases, deletion of EDC3 caused a synergistic mRNA-decapping defect at the permissive temperatures. The edc3
had no effect when combined with the lsm1
, dhh1
, or pat1
mutations, which appear to affect an early step in the decapping pathway. This suggests that Edc3p specifically affects the function of the decapping enzyme per se. Consistent with a functional role in decapping, GFP-tagged Edc3p localizes to cytoplasmic foci involved in mRNA decapping referred to as P-bodies. These results identify Edc3p as a new protein involved in the decapping reaction.
IN eukaryotic cells, mRNA turnover and its regulation are essential determinants of gene expression. In Saccharomyces cerevisiae, a major pathway of mRNA turnover for both stable and unstable transcripts initiates with deadenylation of the 3'-polyadenosine [poly(A)] tail (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Decapping is an important step in the mRNA decay pathway as it allows the final degradation of the mRNA and is regulated by a number of proteins (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
One way to find new factors affecting mRNA decay is to utilize databases of protein-protein interactions on the basis of high-throughput two-hybrid screens, systematic mass spectrometry, and multidimensional protein identification technology screens to find proteins that show numerous interactions with known decapping factors. To do this, we examined the S. cerevisiae genomic-scale data and observed that the yeast open reading frame Yel015W showed numerous interactions with the Dcp1p/Dcp2p complex, Dhh1p, Xrn1p, Pat1p, and members of the Lsm complex (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
| MATERIALS AND METHODS |
|---|
Sequence analysis:
The Edc3p homolog in S. pombe was used as a query to identify homologs in other organisms using the BLAST algorithm (![]()
![]()
![]()
|
Yeast strains and plasmids:
All strains used in this study are listed in Table 1. The NEO deletion cassette from the genomic DNA of the commercially available yel015w
mutant strain (Research Genetics, Birmingham, AL) was PCR amplified using the oligonucleotides oRP 1202 (5'-GAA GCA TAT CGT AAG CAC AC-3') and oRP 1203 (5'-GTG AGA CAC TGG CCT CGT CTG-3'). This amplified PCR fragment was used for transformation of the strains yRP840 and yRP841 to get yRP1745 and yRP1746 strains by homologous recombination.
|
Growth phenotype studies were done with the dcp2-7ski3
edc3
and dcp1-2 ski8
edc3
strains, which were obtained by crossing edc3
with dcp2-7 ski3
and dcp1-2 ski8
strains and dissection of the diploid strains. The triple mutants were then grown along with the wild type (WT) and single and double mutants at 24°, 30°, and 37° for 3 days.
The construction of the Lsm1p-RFP plasmid is described in ![]()
![]()
RNA procedures:
All RNA analyses were performed as described in ![]()
![]()
![]()
![]()
|
|
|
|
A primer extension analysis was performed as described in ![]()
|
Confocal microscopy:
The cells were grown to an OD of 0.4 at 30° in synthetic medium containing 2% dextrose, washed, resuspended in a smaller volume of the media, and observed. Observations were made as described in ![]()
|
| RESULTS |
|---|
Edc3p belongs to a novel class of conserved proteins:
To evaluate the possible significance of Edc3p, we first examined databases for homologs in other organisms. By a series of BLAST (![]()
To determine which regions of Edc3p might be important for its function, we looked for conserved regions by several approaches. When Edc3p and its homologs were aligned using BLAST, a global alignment algorithm, no striking regions of similarity were observed. However, on using the alignment algorithms, CLUSTALW (![]()
![]()
Edc3p is not rate limiting for mRNA decay:
The extensive interactions/associations between Edc3p and different proteins involved in mRNA decay suggested that Edc3p might be involved in mRNA decay. To determine the role of Edc3p in mRNA decay, we created an edc3
strain, which grew normally at temperatures between 18° and 37°. We then analyzed the turnover of two reporter mRNAs in the edc3
strain. Analysis of mRNA degradation in these strains revealed no defect in the decay of either the unstable MFA2pG reporter mRNA (Fig 2) or the stable PGK1pG mRNA (data not shown). For example, the half-life of MFA2pG reporter mRNA was 4.6 min in the edc3
strain, which is not significantly different from the 4-min half-life of MFA2pG in the wild-type strain. This suggests that Edc3p either is not involved in mRNA decay or affects a step in decapping that is not rate limiting in vivo.
edc3
slows mRNA decay in strains compromised for the mRNA decay:
Given the extensive interactions with decapping factors, we hypothesized that Edc3p was involved in mRNA decapping, but affected a step that was not rate limiting. This interpretation was consistent with previous results identifying multiple substeps in the decapping reaction (![]()
![]()
was combined with several mutations affecting decapping at different steps in the process. Specifically, we combined edc3
with conditional alleles in subunits of the decapping enzyme, dcp1-2 and dcp2-7, which affect the actual activity of the decapping enzyme (![]()
![]()
was combined with dhh1
, pat1
, or lsm1
. These latter mutations affect an early step in the decapping pathway that is distinct from the actual catalytic cleavage (![]()
![]()
![]()
We first analyzed the mRNA decay defects of the edc3
dcp1-2 and edc3
dcp2-7 mutant strains. These experiments were done at 24°, which is the permissive temperature for both dcp1-2 and dcp2-7 alleles. At this temperature, dcp1-2 and dcp2-7 alleles are very slightly defective in mRNA decay in vivo at the permissive temperature (![]()
was combined with either the dcp1-2 or the dcp2-7 background we observed a decrease in the rate of decay of the MFA2pG (Fig 3) and the PGK1pG mRNA (data not shown). In the dcp2-7 background, the edc3
slowed the MFA2pG mRNA decay by at least twofold so that the half-life for the MFA2pG mRNA was increased to 12 min compared to the 5 min in strains with just the dcp2-7 allele. The effect on MFA2pG half-life was not so dramatic (7.2 min) in the dcp1-2 strains deleted for the EDC3 gene compared to the dcp1-2 strain alone (4 min). These results indicate that when Dcp2p, and possibly Dcp1p, are partially defective, a role for Edc3p in mRNA decay can be observed. In contrast, when the edc3
was combined with the dhh1
, lsm1
, or pat1
, no affect on decay rate was observed (Fig 3). We interpret these results to indicate that Edc3p functions as an enhancer of mRNA decapping and genetically interacts most strongly with the actual decapping enzyme.
Loss of EDC3 slows growth in cells compromised for mRNA decapping:
To obtain additional evidence that Edc3p affected decapping, we utilized a growth assay where the viability of the strains is dependent on efficient mRNA decapping. This assay is based on the observation that strains lacking both the major deadenylation-dependent decapping pathway and the alternative 3'5' degradation pathway are dead (![]()
![]()
or ski8
. For example, a dcp1-2 ski8
strain grows at 24°, but is dead at 33° (![]()
grows at 24° and 30° but is dead at 37° (![]()
should exacerbate the growth defect in the dcp1-2 ski8
and dcp2-7 ski3
strains and we would see a synthetic lethality at a temperature <33° or 37°.
We observed that combining the edc3
in strains with the dcp1-2 ski8
and dcp2-7 ski3
did lead to a clear exacerbation of the growth defects (Fig 4). At 24°, the dcp2-7 ski3
edc3
had an extremely slow growth phenotype compared to just the dcp2-7 ski3
. Moreover, the dcp2-7 ski3
edc3
failed to grow at 30° in comparison to the dcp2-7 ski3
that showed normal growth. Combination of edc3
with dcp1-2 ski8
also showed a growth defect phenotype at 30°, but almost normal growth at 24° in comparison to just the dcp1-2 ski8
strain that grows normally at both 30° and 24°. These growth defects correspond well with the mRNA decay phenotype of these mutants where Edc3p showed a greater defect when combined with the dcp2-7 allele than when combined with the dcp1-2 allele. These data provide a second line of genetic evidence for Edc3p affecting decapping.
Edc3p deletion affects the decapping step in mRNA decay:
Mutations affecting the mRNA decay rate in yeast can be at any step during deadenylation, decapping, or 5'3' exonucleolytic degradation. The edc3
showed an mRNA decay defect phenotype only when combined in strains with either the dcp1-2 or the dcp2-7 mutation. Therefore, the most probable hypothesis is that Edc3p affects the decapping step of mRNA decay, which would be consistent with known Edc3p physical interactions. To determine what step in decapping Edc3p affects, we compared the decay of the MFA2pG mRNA in dcp2-7 strains to dcp2-7 edc3
strains on polyacrylamide Northern gels, where the rates of deadenylation and subsequent decay can be observed. On analysis of the MFA2pG mRNA, we observed that there was no substantial difference in the deadenylation rate of the MFA2pG mRNA among the wild type, edc3
, dcp2-7, or dcp2-7 edc3
strains (Fig 5). This indicates that Edc3p does not affect the deadenylation rate. However, we did observe that the decay of the deadenylated species was slower in the dcp2-7 edc3
as compared to dcp2-7 strains alone. This observation suggests that the Edc3p promotes either decapping or 5'3' exonucleolytic degradation in the dcp2-7 strain.
A defect in mRNA decapping can be distinguished from a defect in the exonucleolytic digestion by a primer extension assay. This assay takes advantage of the observation that strains defective in 5'3' degradation accumulate a decapped PGK1 transcript that is two nucleotides shorter at the 5' end compared to that of transcripts that still have the cap (![]()
![]()
![]()
, dcp2-7 edc3
, and various control strains including the xrn1
strain (lacking the 5'3' exonuclease) and dcp1
(lacking the decapping enzyme) strains. We observed that the dcp2-7 edc3
strain, where there is a defect in decay after deadenylation, contains a full-length transcript similar to only the wild-type and dcp1
strains. Further, the edc3
mutants did not have a defect exclusively in the 3'5' exonuclease activity. In contrast, the xrn1
strain shows the full-length transcript and a -2-nucleotide (nt) species (Fig 6). The above observations provide evidence that Edc3p affects the decapping step of mRNA degradation. However, it should be noted that we cannot rule out that Edc3p also affects the 5'3' degradation step.
Edc3p localizes to cytoplasmic foci similar to the P-bodies:
It has been recently shown that the proteins involved specifically in mRNA decapping in yeast and mammals are concentrated in cytoplasmic foci called P-bodies (![]()
![]()
![]()
![]()
Additional supporting evidence that the Edc3p-GFP foci are P-bodies comes from the observation that trapping mRNAs in polysomes using cycloheximide inhibits decapping and leads to loss of P-bodies after treatment with the drug (![]()
Edc3p does not affect nonsense-mediated decay:
The decapping complex is also involved in nonsense-mediated decay (NMD), which is characterized by deadenylation-independent decapping; therefore we asked if Edc3p plays a role in NMD (![]()
![]()
and dcp2-7 edc3
strains were analyzed. A known NMD substrate is the CYH2 pre-mRNA, which is inefficiently spliced and contains a pretermination codon (PTC; ![]()
![]()
did not lead to increased levels of pre-CYH2 mRNA either in wild-type strains or in combination with dcp1-2 and dcp2-7 alleles (Fig 8). These results suggest that Edc3p does not play a significant role in NMD.
|
| DISCUSSION |
|---|
Several observations indicate that Edc3p has a role in mRNA decay and specifically enhances the function of decapping. First, Edc3p has been shown in numerous in vivo and in vitro genomic studies to physically interact with several mRNA decay factors (![]()
![]()
![]()
![]()
![]()
dcp2-7 strains accumulated deadenylated full-length MFA2pG reporter mRNA compared to the WT, edc3
, and dcp2-7 allele alone (Fig 5). Third, edc3
exaggerated growth defects and caused synthetic lethality in strains containing the dcp1-2 and dcp2-7 alleles in combination with a block to the 3'5' decay pathway (Fig 4). Finally, an Edc3p-GFP fusion protein localizes in P-bodies (Fig 7), which are specialized cytoplasmic foci containing decapping proteins (![]()
In principle, Edc3p could enhance decapping by acting at any of several distinct steps in the decapping process. Although poorly understood, previous experiments have suggested that decapping will require at least three distinct, but possibly related steps: (1) loss of the translation initiation complex bound to the 5' end of the mRNA, (2) assembly of a decapping complex and localization within P-bodies, and (3) the actual catalytic step of decapping (![]()
![]()
![]()
Three observations are consistent with Edc3p primarily affecting the final step of enzymatic decapping, either by stabilizing Dcp1p/Dcp2p or by affecting their function in some manner. First, the edc3
shows only synergistic effects with other defects in the decapping activity and does not show any phenotypic interaction with deletions in the LSM1, PAT1, and DHH1 genes, whose products are likely to affect the first two steps in the decapping process. Second, on the basis of copurification, Edc3p directly interacts with Dcp1p/Dcp2p (![]()
![]()
![]()
![]()
![]()
does not have a decay defect and previous results suggest that the actual decapping step in decay is not normally rate limiting. Evidence that the enzymatic decapping step is not rate limiting in vivo in our growth conditions is that the dcp1-2, dcp2-7, edc1
, and edc2
mutations all strongly affect mRNA decapping activity in vitro, yet have little effect on overall decay rate in vivo (![]()
![]()
The Edc3p is part of an emerging set of proteins that perform the mRNA decapping step. Proteins involved in mRNA decay can be divided into three functional and phenotypic categories. The first class of proteins consists of Dcp1p and Dcp2p, which are required for the decapping enzyme to function, and strains lacking these proteins show a complete block to decapping (![]()
![]()
![]()
Recent results suggest that the EDC family of proteins may also be important in the control of a subset of mRNAs or in the control of decapping under different conditions. For example, Edc1p has been shown to be important for growth during a shift from dextrose to glycerol, suggesting that it may be affecting specific mRNAs necessary for this carbon-source shift (![]()
| ACKNOWLEDGMENTS |
|---|
We thank the Parker laboratory for helpful discussions; Ujwal Sheth for the Edc3p-GFP strain and the LSM1-RFP plasmid; and Kristian Baker, Jeffery Coller, Carolyn Decker, Tharun Sundaresan, and Daniela Teixiera for experimental and intellectual assistance. We also thank Alain Jacquier for sharing unpublished results. A National Institutes of Health grant (GM45443) and funds from the Howard Hughes Medical Institute supported this work.
Manuscript received July 8, 2003; Accepted for publication October 27, 2003.
| LITERATURE CITED |
|---|
ALTSCHUL, S. F., W. GISH, W. MILLER, E. W. MYERS, and D. J. LIPMAN, 1990 Basic local alignment search tool. J. Mol. Biol. 215:403-410.[CrossRef][Medline]
BEELMAN, C. A., A. STEVENS, G. CAPONIGRO, T. E. LAGRANDEUR, and L. HATFIELD et al., 1996 An essential component of the decapping enzyme required for normal rates of mRNA turnover. Nature 382:642-646.[CrossRef][Medline]
BONNEROT, C., R. BOECK, and B. LAPEYRE, 2000 The two proteins Pat1p (Mrt1p) and Spb8p interact in vivo, are required for mRNA decay, and are functionally linked to Pab1p. Mol. Cell. Biol. 20:5939-5946.
BOUVERET, E., G. RIGAUT, A. SHEVCHENKO, M. WILM, and B. SERAPHIN, 2000 A Sm-like protein complex that participates in mRNA degradation. EMBO J. 19:1661-1671.[CrossRef][Medline]
CAPONIGRO, G. and R. PARKER, 1996 mRNA turnover in yeast promoted by the MATalpha1 instability element. Nucleic Acids Res. 24:4304-4312.
CAPONIGRO, G., D. MUHLRAD, and R. PARKER, 1993 A small segment of the MAT alpha 1 transcript promotes mRNA decay in Saccharomyces cerevisiae: a stimulatory role for rare codons. Mol. Cell. Biol. 13:5141-5148.
CHEN, J., Y. C. CHIANG, and C. L. DENIS, 2002 CCR4, a 3'-5' poly (A) RNA and ssDNA exonuclease, is the catalytic component of the cytoplasmic deadenylase. EMBO J. 21:1414-1426.[CrossRef][Medline]
COLLER, J. M., M. TUCKER, U. SHETH, M. A. VALENCIA-SANCHEZ, and R. PARKER, 2001 The DEAD box helicase, Dhh1p, functions in mRNA decapping and interacts with both the decapping and deadenylase complexes. RNA 7:1717-1727.[Abstract]
DAUGERON, M. C., F. MAUXION, and B. SERAPHIN, 2001 The yeast POP2 gene encodes a nuclease involved in mRNA deadenylation. Nucleic Acids Res. 29:2448-2455.
DECKER, C. J. and R. PARKER, 1993 A turnover pathway for both stable and unstable mRNAs in yeast: evidence for a requirement for deadenylation. Genes Dev. 7:1632-1643.
DUNCKLEY, T. and R. PARKER, 1999 The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif. EMBO J. 18:5411-5422.[CrossRef][Medline]
DUNCKLEY, T., M. TUCKER, and R. PARKER, 2001 Two related proteins, Edc1p and Edc2p, stimulate mRNA decapping in Saccharomyces cerevisiae. Genetics 157:27-37.
FISCHER, N. and K. WEIS, 2002 The DEAD box protein Dhh1 stimulates the decapping enzyme Dcp1. EMBO J. 21:2788-2797.[CrossRef][Medline]
FROMONT-RACINE, M., J. C. RAIN, and P. LEGRAIN, 1997 Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens. Nat. Genet. 16:277-282.[CrossRef][Medline]
FROMONT-RACINE, M., A. E. MAYES, A. BRUNET-SIMON, J. C. RAIN, and A. COLLEY et al., 2000 Genome-wide protein interaction screens reveal functional networks involving Sm-like proteins. Yeast 17:95-110.[CrossRef][Medline]
GAVIN, A. C., M. BOSCHE, R. KRAUSE, P. GRANDI, and M. MARZIOCH et al., 2002 Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415:141-147.[CrossRef][Medline]
GIAEVER, G., A. M. CHU, L. NI, C. CONNELLY, and L. RILES et al., 2002 Functional profiling of the Saccharomyces cerevisiae genome. Nature 418:387-391.[CrossRef][Medline]
HATFIELD, L., C. A. BEELMAN, A. STEVENS, and R. PARKER, 1996 Mutations in trans-acting factors affecting mRNA decapping in Saccharomyces cerevisiae. Mol. Cell. Biol. 16:5830-5838.[Abstract]
HE, F., S. W. PELTZ, J. L. DONAHUE, M. ROSBASH, and A. JACOBSON, 1993 Stabilization and ribosome association of unspliced pre-mRNAs in a yeast upf1- mutant. Proc. Natl. Acad. Sci. USA 90:7034-7038.
HE, W. and R. PARKER, 2001 The yeast cytoplasmic LsmI/Pat1p complex protects mRNA 3' termini from partial degradation. Genetics 158:1445-1455.
HENIKOFF, S., J. G. HENIKOFF, W. J. ALFORD, and S. PIETROKOVSKI, 1995 Automated construction and graphical presentation of protein blocks from unaligned sequences. Gene 163:GC17-GC26.[CrossRef][Medline]
HILLEREN, P. and R. PARKER, 1999 Mechanisms of mRNA surveillance in eukaryotes. Annu. Rev. Genet. 33:229-260.[CrossRef][Medline]
HISHIGAKI, H., K. NAKAI, T. ONO, A. TANIGAMI, and T. TAKAGI, 2001 Assessment of prediction accuracy of protein function from proteinprotein interaction data. Yeast 18:523-531.[CrossRef][Medline]
HO, Y., A. GRUHLER, A. HEILBUT, G. D. BADER, and L. MOORE et al., 2002 Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415:180-183.[CrossRef][Medline]
HSU, C. L. and A. STEVENS, 1993 Yeast cells lacking 5'
3' exoribonuclease 1 contain mRNA species that are poly (A) deficient and partially lack the 5' cap structure. Mol. Cell. Biol. 13:4826-4835.
INGELFINGER, D., D. J. ARNDT-JOVIN, R. LUHRMANN, and T. ACHSEL, 2002 The human LSm17 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci. RNA 8:1489-1501.[Abstract]
ITO, T., T. CHIBA, R. OZAWA, M. YOSHIDA, and M. HATTORI et al., 2001 A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc. Natl. Acad. Sci. USA 98:4569-4574.
JACOBS, J. S., A. R. ANDERSON, and R. P. PARKER, 1998 The 3' to 5' degradation of yeast mRNAs is a general mechanism for mRNA turnover that requires the SKI2 DEVH box protein and 3' to 5' exonucleases of the exosome complex. EMBO J. 17:1497-1506.[CrossRef][Medline]
LONGTINE, M. S., A. MCKENZIE, III, D. J. DEMARINI, N. G. SHAH, and A. WACH et al., 1998 Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14:953-961.[CrossRef][Medline]
LYKKE-ANDERSEN, J., 2002 Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay. Mol. Cell. Biol. 22:8114-8121.
MUHLRAD, D. and R. PARKER, 1992 Mutations affecting stability and deadenylation of the yeast MFA2 transcript. Genes Dev. 6:2100-2111.
MUHLRAD, D., C. J. DECKER, and R. PARKER, 1994 Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5'
3' digestion of the transcript. Genes Dev. 8:855-866.
MUHLRAD, D., C. J. DECKER, and R. PARKER, 1995 Turnover mechanisms of the stable yeast PGK1 mRNA. Mol. Cell. Biol. 15:2145-2156.[Abstract]
SCHWARTZ, D. C. and R. PARKER, 2000 mRNA decapping in yeast requires dissociation of the cap binding protein, eukaryotic translation initiation factor 4E. Mol. Cell. Biol. 20:7933-7942.
SCHWARTZ, D., C. J. DECKER, and R. PARKER, 2003 The enhancer of decapping proteins, Edc1p and Edc2p, bind RNA and stimulate the activity of the decapping enzyme. RNA 9:239-251.
SCHWIKOWSKI, B., P. UETZ, and S. FIELDS, 2000 A network of protein-protein interactions in yeast. Nat. Biotechnol. 18:1257-1261.[CrossRef][Medline]
SHETH, U. and R. PARKER, 2003 Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300:805-808.
STEIGER, M. A. and R. PARKER, 2002 Analyzing mRNA decay in Saccharomyces cerevisiae. Methods Enzymol. 351:648-660.[Medline]
STEIGER, M., A. CARR-SCHMID, D. C. SCHWARTZ, M. KILEDJIAN, and R. PARKER, 2003 Analysis of recombinant yeast decapping enzyme. RNA 9:231-238.
THARUN, S. and R. PARKER, 1999 Analysis of mutations in the yeast mRNA decapping enzyme. Genetics 151:1273-1285.
THARUN, S. and R. PARKER, 2001 Targeting an mRNA for decapping: displacement of translation factors and association of the Lsm1p-7p complex on deadenylated yeast mRNAs. Mol. Cell 8:1075-1083.[CrossRef][Medline]
THARUN, S., W. HE, A. E. MAYES, P. LENNERTZ, and J. D. BEGGS et al., 2000 Yeast Sm-like proteins function in mRNA decapping and decay. Nature 404:515-518.[CrossRef][Medline]
THOMPSON, J. D., D. G. HIGGINS, and T. J. GIBSON, 1994 CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
TUCKER, M. and R. PARKER, 2000 Mechanisms and control of mRNA decapping in Saccharomyces cerevisiae. Annu. Rev. Biochem. 69:571-595.[CrossRef][Medline]
TUCKER, M., M. A. VALENCIA-SANCHEZ, R. R. STAPLES, J. CHEN, and C. L. DENIS et al., 2001 The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae. Cell 104:377-386.[CrossRef][Medline]
TUCKER, M., R. R. STAPLES, M. A. VALENCIA-SANCHEZ, D. MUHLRAD, and R. PARKER, 2002 Ccr4p is the catalytic subunit of a Ccr4p/Pop2p/Notp mRNA deadenylase complex in Saccharomyces cerevisiae. EMBO J. 21:1427-1436.[CrossRef][Medline]
UETZ, P., L. GIOT, G. CAGNEY, T. A. MANSFIELD, and R. S. JUDSON et al., 2000 A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403:623-627.[CrossRef][Medline]
VAN DIJK, E., N. COUGOT, S. MEYER, S. BABAJKO, and E. WAHLE et al., 2002 Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J. 21:6915-6924.[CrossRef][Medline]
VAN HOOF, A., R. R. STAPLES, R. E. BAKER, and R. PARKER, 2000 Function of the ski4p (Csl4p) and Ski7p proteins in 3'-to-5' degradation of mRNA. Mol. Cell. Biol. 20:8230-8243.
WILUSZ, C. J., W. WANG, and S. W. PELTZ, 2001 Curbing the nonsense: the activation and regulation of mRNA surveillance. Genes Dev. 15:2781-2785.
ZUK, D., J. P. BELK, and A. JACOBSON, 1999 Temperature-sensitive mutations in the Saccharomyces cerevisiae MRT4, GRC5, SLA2 and THS1 genes result in defects in mRNA turnover. Genetics 153:35-47.
This article has been cited by other articles:
![]() |
F. Tritschler, A. Eulalio, S. Helms, S. Schmidt, M. Coles, O. Weichenrieder, E. Izaurralde, and V. Truffault Similar Modes of Interaction Enable Trailer Hitch and EDC3 To Associate with DCP1 and Me31B in Distinct Protein Complexes Mol. Cell. Biol., November 1, 2008; 28(21): 6695 - 6708. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. M. Ling, C. J. Decker, M. A. Walsh, M. She, R. Parker, and H. Song Crystal Structure of Human Edc3 and Its Functional Implications Mol. Cell. Biol., October 1, 2008; 28(19): 5965 - 5976. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chowdhury and S. Tharun lsm1 mutations impairing the ability of the Lsm1p-7p-Pat1p complex to preferentially bind to oligoadenylated RNA affect mRNA decay in vivo RNA, October 1, 2008; 14(10): 2149 - 2158. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Decourty, C. Saveanu, K. Zemam, F. Hantraye, E. Frachon, J.-C. Rousselle, M. Fromont-Racine, and A. Jacquier Linking functionally related genes by sensitive and quantitative characterization of genetic interaction profiles PNAS, April 15, 2008; 105(15): 5821 - 5826. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marin, S. Golem, K. M. Rose, S. L. Kozak, and D. Kabat Human Immunodeficiency Virus Type 1 Vif Functionally Interacts with Diverse APOBEC3 Cytidine Deaminases and Moves with Them between Cytoplasmic Sites of mRNA Metabolism J. Virol., January 15, 2008; 82(2): 987 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tritschler, A. Eulalio, V. Truffault, M. D. Hartmann, S. Helms, S. Schmidt, M. Coles, E. Izaurralde, and O. Weichenrieder A Divergent Sm Fold in EDC3 Proteins Mediates DCP1 Binding and P-Body Targeting Mol. Cell. Biol., December 15, 2007; 27(24): 8600 - 8611. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Decker, D. Teixeira, and R. Parker Edc3p and a glutamine/asparagine-rich domain of Lsm4p function in processing body assembly in Saccharomyces cerevisiae J. Cell Biol., November 5, 2007; 179(3): 437 - 449. [Abstract] [Full Text] [PDF] |
||||












